Table 2 Comparisons of genotype results of study patients between genotype-based dosing group and standard dosing group.
Minor allele frequency | Genotype | Total | Genotype-guided dosing group | Standard dosing Group | P-value | |
|---|---|---|---|---|---|---|
VKORC1 | 0.08 | CC | 2 (2.2) | 0(0) | 2 (4.1) | 0.370 |
rs9934438 (C > T) | CT | 10 (11.0) | 4 (9.5) | 6 (12.2) | ||
TT | 79 (86.8) | 38 (90.5) | 41 (83.7) | |||
CYP2C9 | 0.03 | AA | 85 (93.4) | 40 (95.2) | 45 (91.8) | 0.683 |
rs1057910 (A > C) | AC | 6 (6.6) | 2 (4.8) | 4 (8.2) | ||
CYP4F2 | 0.31 | GG | 43 (47.3) | 21 (50.0) | 22 (44.9) | 0.698 |
rs2108622 (G > A) | GA | 39 (42.9) | 18 (42.9) | 21 (42.9) | ||
AA | 9 (9.9) | 3 (7.1) | 6 (12.2) |
